Dr. Santanu AcharyaRadiation OncologistMBBS, MD - RadiotherapyCareClues11 years experience
Share your experienceShare Profile

Services

  • Intensity-Modulated Radiation Therapy
  • Image-Guided Radiation Therapy (IGRT)
  • Rapid Arc

Specializations

  • Radiation Oncologist

Awards and Recognitions

  • College scholarship in MBBS
  • Facilitator in MCI recognized MET programmed
  • Pattern of leocoregional recurrence in TNBC- Retrospective study in BSMC Bankura
  • Speaker in different cancer controlled programs organized by IMA
  • Speaker in different National Level Seminar
  • Attend different National Conference
  • Chair person of 1st teaching workshop organized by radiation therapy technologist in India
  • Induction Chemotherapy Followed By concurrent chemoradiotherapy versus radiotherapy alone in locally advanced HNSCC-An Experience From Medical College in West Bengal : IRA- International Journal of Applied Sciences /vol 3/ issue 02(May 2016)
  • Malignant chondroid syringoma in the ant abdominal wall : a case report; Journal of evolution of medical & dental sciences/ vol 2/ issue 29/ July 22.2013
  • A retrospective study of bladder cancer & the impact of age , sex and smoking habits with related clinicpathology correlations in the tribal population of Bankura, WB, India: Journal of dental & medical sciences/vol 10 / issue 4(sep – oct.2013)
  • A retrospective study of prognostic factors in locally advanced cancer of uterine cervix in a rural medical college of West Bengal, Journal of dental & medical sciences/ vol 13 / issue 3(March,2014)
  • Incidental finding of gall bladder carcinoma : A retrospective study; Indian medical gazette. Vol CXLVI March 2012.
  • Retrospective study of Geftinib as a second line treatment in lung cancer, Indian medical gazette.vol CXLV October,2011
  • Retrospective study comparing First generation 5HT3 receptor antagonist (Ondansetron) vs. second generation 5HT3 receptor antagonist(Palonocetron) in the prevention of chemotherapy induced nausea and vomiting (CINV) Indian medical gazette.vol CXLV ,May,2011.
  • Skin rash as a surrogate marker of clinical response targeted therapy using Geftinib in advanced or metastatic non small cell lung cancer: JIMA,vol110(7),July,2012
  • Assesment of prognostic factors for locally advanced breast cancer:JIMA,vol 110(5),May,2012
  • Results of diagnostic dilemma between lung cancer & sputum negative pulmonary tuberculosis, A retrospective study, JIMA , vol110(12), December, 2012

Experience

  • RGKAR Medical College, Kolkata, Associate Professor Department of Oncology
  • Apollo Gleneagles Hospital, Kolkata, Radiation Oncologist
  • Renaissance Hospital, Consultant

Registrations

  • 50444 , 1993
Plot No. DG-6, Service Road, Street Number 358, DG Block(Newtown), Action Area I, NewtownOhio Hospital
No schedules available.